(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 122.35%630.3M | ---- | 207.02%283.47M | ---- | -126.01%-264.87M | ---- | -1.28%1.02B | ---- | -32.91%1.03B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -132.57%-89.61M | ---- | -131.90%-38.53M | ---- | 61.50%-16.62M | ---- | 61.80%-43.16M | ---- | -25.66%-112.98M |
Attributable subsidiary (profit) loss | ---- | 477.85%114.5M | ---- | 44.63%-30.3M | ---- | -194.15%-54.72M | ---- | -132.82%-18.6M | ---- | 363.69%56.68M |
Impairment and provisions: | ---- | -53.79%54.89M | ---- | -86.32%118.78M | ---- | --868.51M | ---- | ---- | ---- | 663.24%273.45M |
-Impairment of property, plant and equipment (reversal) | ---- | -59.77%37.1M | ---- | -29.46%92.21M | ---- | --130.72M | ---- | ---- | ---- | --114.38M |
-Impairment of goodwill | ---- | ---- | ---- | --42.09M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | 214.62%17.79M | ---- | -102.10%-15.52M | ---- | --737.79M | ---- | ---- | ---- | 343.99%159.07M |
Revaluation surplus: | ---- | 638.45%39.43M | ---- | 81.58%-7.32M | ---- | -482.49%-39.76M | ---- | 44.18%-6.83M | ---- | -563.12%-12.23M |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.00%8M | ---- | --5M |
-Other fair value changes | ---- | 638.45%39.43M | ---- | 81.58%-7.32M | ---- | -168.18%-39.76M | ---- | 13.94%-14.83M | ---- | -834.27%-17.23M |
Asset sale loss (gain): | ---- | -19.46%10.19M | ---- | -52.45%12.65M | ---- | -49.54%26.61M | ---- | 2,635.06%52.73M | ---- | 102.79%1.93M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -102.29%-682K | ---- | -52.38%29.79M | ---- | 3,144.66%62.56M | ---- | 102.79%1.93M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -4.39%12.75M | ---- | --13.34M | ---- | ---- | ---- | --12.2M | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---2.56M | ---- | ---- | ---- | 85.57%-3.18M | ---- | ---22.03M | ---- | ---- |
Depreciation and amortization: | ---- | 19.83%1.89B | ---- | -6.44%1.58B | ---- | 42.89%1.69B | ---- | 13.66%1.18B | ---- | 7.94%1.04B |
-Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.07B | ---- | ---- |
-Amortization of intangible assets | ---- | 40.02%180.49M | ---- | -31.62%128.91M | ---- | 68.86%188.52M | ---- | -17.00%111.64M | ---- | 39.83%134.51M |
Financial expense | ---- | -15.85%1.52B | ---- | 18.74%1.8B | ---- | 14.73%1.52B | ---- | 9.38%1.32B | ---- | 24.10%1.21B |
Special items | ---- | -393.42%-378.95M | ---- | -1,115.59%-76.8M | ---- | 60.60%-6.32M | ---- | -752.07%-16.04M | ---- | -529.68%-1.88M |
Operating profit before the change of operating capital | ---- | 4.01%3.79B | ---- | -2.01%3.64B | ---- | 6.53%3.72B | ---- | 0.15%3.49B | ---- | 3.66%3.49B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 309.13%20.99M | ---- | -121.08%-10.04M | ---- | -44.87%47.61M | ---- | 196.26%86.36M | ---- | 23.75%-89.72M |
Accounts receivable (increase)decrease | ---- | -82.58%163.66M | ---- | 170.23%939.53M | ---- | 46.08%-1.34B | ---- | -154.66%-2.48B | ---- | -124.51%-974.24M |
Accounts payable increase (decrease) | ---- | -89.54%-1.75B | ---- | 80.36%-923.15M | ---- | -161.96%-4.7B | ---- | -215.19%-1.79B | ---- | 212.46%1.56B |
prepayments (increase)decrease | ---- | 55.78%-151.31M | ---- | -113.30%-342.2M | ---- | 696.60%2.57B | ---- | 52.12%-431.19M | ---- | -13.76%-900.5M |
Special items for working capital changes | ---- | 20.94%249.98M | ---- | -76.88%206.69M | ---- | -62.50%893.82M | ---- | 350.88%2.38B | ---- | -32.04%-949.97M |
Cash from business operations | ---- | -42.45%2.25B | ---- | 53.91%3.91B | ---- | 39.82%2.54B | ---- | -1.21%1.82B | ---- | 6.25%1.84B |
China income tax paid | ---- | -2.28%-253.95M | ---- | 0.04%-248.29M | ---- | -22.87%-248.39M | ---- | 20.32%-202.16M | ---- | 10.33%-253.71M |
Other taxs | ---- | -118.22%-72.4M | ---- | -70.47%397.43M | ---- | 139.02%1.35B | ---- | 295.09%563.13M | ---- | -332.11%-288.66M |
Special items of business | -12.90%661.25M | 118.22%72.4M | -46.82%759.21M | 70.47%-397.43M | 120.50%1.43B | -139.02%-1.35B | -41.86%647.46M | -295.09%-563.13M | -6.90%1.11B | 332.11%288.66M |
Net cash from operations | -12.90%661.25M | -45.48%2B | -46.82%759.21M | 59.75%3.66B | 120.50%1.43B | 41.94%2.29B | -41.86%647.46M | 1.85%1.62B | -6.90%1.11B | 9.49%1.59B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 59.12%32.49M | 132.57%89.61M | 193.15%20.42M | 131.90%38.53M | 69.92%6.97M | -61.50%16.62M | -68.88%4.1M | -61.80%43.16M | -66.73%13.17M | 25.66%112.98M |
Dividend received - investment | ---- | --4.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Restricted cash (increase) decrease | 288.53%66.9M | 83.56%-6.67M | -6.00%-35.49M | -123.10%-40.56M | -116.70%-33.48M | 473.75%175.6M | 335.08%200.43M | -128.61%-46.98M | -65.05%46.07M | -11.85%164.2M |
Loan receivable (increase) decrease | ---- | -71.53%44.89M | ---- | -57.81%157.68M | ---- | -49.10%373.72M | ---- | --734.18M | ---- | ---- |
Sale of fixed assets | --1.27M | -53.06%4.44M | ---- | 68.17%9.46M | --1.42M | -55.86%5.63M | ---- | 9,202.92%12.75M | 6,116.07%47.18M | -85.14%137K |
Purchase of fixed assets | 53.19%-465.41M | -65.74%-1.6B | -185.99%-994.35M | 28.24%-966.38M | 44.78%-347.69M | 36.60%-1.35B | 60.14%-629.6M | 35.85%-2.12B | 0.88%-1.58B | 3.66%-3.31B |
Purchase of intangible assets | 66.38%-2.77M | -183.40%-39.8M | -43,257.89%-8.24M | 159.68%47.72M | 99.86%-19K | 67.72%-79.96M | 41.16%-13.25M | -29.65%-247.72M | 43.85%-22.52M | 26.40%-191.07M |
Sale of subsidiaries | ---- | 543.37%28.44M | 136.92%2.46M | -135.07%-6.41M | ---6.65M | -97.06%18.29M | ---- | 2,392.79%621.33M | 2,381.37%599.45M | -96.87%24.93M |
Acquisition of subsidiaries | ---- | -6.62%-268.26M | ---261.69M | -95.06%-251.61M | ---- | 82.06%-128.99M | -188.35%-3.97M | -1,127.96%-718.85M | 116.61%4.49M | 93.25%-58.54M |
Recovery of cash from investments | --148.38M | -87.74%56.67M | ---- | 67.92%462.31M | --356.9M | --275.32M | ---- | ---- | ---- | --17.79M |
Cash on investment | 99.86%-704K | -35.19%-670.08M | -1,139.88%-492.02M | 50.21%-495.66M | -173.52%-39.68M | 14.73%-995.56M | 103.12%53.98M | -61.67%-1.17B | -602.58%-1.73B | 46.27%-722.18M |
Other items in the investment business | -617.22%-575.72M | 36.41%-214.77M | 111.48%111.31M | 59.72%-337.74M | 18.56%-969.78M | -1,946.06%-838.57M | -238.67%-1.19B | 106.49%45.43M | 172.00%858.69M | 61.48%-699.47M |
Net cash from investment operations | 52.00%-795.57M | -86.07%-2.57B | -60.62%-1.66B | 45.23%-1.38B | 34.64%-1.03B | 11.36%-2.52B | 10.43%-1.58B | 38.91%-2.85B | 42.34%-1.76B | 25.89%-4.66B |
Net cash before financing | 85.05%-134.32M | -125.19%-574.78M | -327.06%-898.39M | 1,089.45%2.28B | 142.47%395.66M | 81.28%-230.63M | -43.50%-931.58M | 59.94%-1.23B | 65.11%-649.18M | 36.48%-3.08B |
Cash flow from financing activities | ||||||||||
New borrowing | 31.00%6.1B | -31.69%9.37B | -33.21%4.66B | 53.90%13.72B | 50.35%6.98B | 48.22%8.92B | 324.99%4.64B | -16.75%6.02B | -73.70%1.09B | 260.79%7.23B |
Refund | -127.73%-7.33B | 22.03%-10.2B | 58.57%-3.22B | -64.34%-13.08B | -176.54%-7.77B | -31.19%-7.96B | -820.00%-2.81B | -159.56%-6.07B | -138.62%-305.46M | -154.36%-2.34B |
Issuing shares | ---- | ---- | ---- | --4.69B | --4.68B | ---- | ---- | ---- | ---- | ---- |
Issuance of bonds | ---- | 74.95%-147.02M | ---- | -5.91%-586.9M | ---- | -154.99%-554.15M | ---- | 80.91%1.01B | --978.55M | -50.74%557.05M |
Interest paid - financing | 8.81%-722.6M | 4.15%-1.53B | -12.86%-792.43M | -19.27%-1.59B | 4.73%-702.16M | -0.01%-1.34B | 1.51%-737.05M | 1.94%-1.34B | -15.88%-748.35M | -29.90%-1.36B |
Dividends paid - financing | ---20.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---7.05M | ---- | ---- |
Absorb investment income | --2.17B | --4.42B | ---- | ---- | ---- | 358.29%7.74M | --600K | -97.44%1.69M | ---- | -39.36%65.89M |
Issuance expenses and redemption of securities expenses | 5.38%-74.47M | ---- | 92.76%-78.71M | ---- | ---1.09B | ---1.22B | ---- | ---- | ---- | ---- |
Other items of the financing business | -1,234.62%-97.07M | 100.45%12.71M | -77.07%8.56M | -399.63%-2.8B | -98.07%37.3M | 365.19%933.24M | 41.59%1.93B | -51.31%200.62M | 105.58%1.37B | -89.09%412.05M |
Net cash from financing operations | -95.87%23.85M | 454.23%1.94B | -72.91%577.15M | 128.83%349.56M | 180.24%2.13B | -555.21%-1.21B | 506.14%760.19M | -104.06%-185.04M | -105.47%-187.17M | 33.79%4.56B |
Effect of rate | 16.86%-114.54M | 20.45%-107.43M | -546.31%-137.76M | -316.65%-135.05M | -189.21%-21.32M | -74.01%62.33M | 139.45%23.89M | 167.53%239.81M | -154.85%-60.56M | -57.50%-355.11M |
Net Cash | 65.61%-110.47M | -48.22%1.36B | -112.72%-321.24M | 282.36%2.63B | 1,573.85%2.53B | -1.83%-1.44B | 79.51%-171.39M | -195.39%-1.42B | -153.64%-836.35M | 203.72%1.49B |
Begining period cash | 34.51%4.89B | 218.83%3.64B | 218.83%3.64B | -54.76%1.14B | -54.76%1.14B | -31.83%2.52B | -31.83%2.52B | 44.02%3.7B | 44.02%3.7B | -39.23%2.57B |
Cash at the end | 46.85%4.67B | 34.51%4.89B | -12.82%3.18B | 218.83%3.64B | 53.56%3.65B | -54.76%1.14B | -15.27%2.37B | -31.83%2.52B | -31.72%2.8B | 44.02%3.7B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data